Get started
Author

E. V. Popova

ORCID: 0000-0003-1242-759X
Observed ORCID: 0000-0003-1242-759X
OpenAlex ID: A5020201277
Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review
2022 · K. V. Menshikov, A. V. Sultanbaev, et al. · Creative Surgery and Oncology · 5
PDF
Immunotherapy of advanced hepatocellular carcinoma: case report and literature review
2022 · K. V. Menshikov, A. V. Sultanbaev, et al. · Meditsinskiy sovet = Medical Council · 3
PDF
Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review
2022 · K. V. Menshikov, A. V. Sultanbaev, et al. · Creative Surgery and Oncology · 3
PDF
The Role of miR-34a in Predicting the Efficacy of Immunotherapy in Clear Cell Renal Cell Carcinoma
2025 · D. D. Asadullina, A. A. Izmailov, et al. · Russian Journal of Genetics
Combined Use of Cabozantinib and Nivolumab in Clinical Practice
2024 · V. E. Askarov, A. V. Sultanbaev, et al. · Creative Surgery and Oncology
PDF
Eribulin in Metastatic Breast Cancer: Actual Clinical Practice
2023 · A. V. Sultanbaev, K. V. Menshikov, et al. · Creative Surgery and Oncology
PDF
Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
2022 · K. V. Menshikov, A. V. Sultanbaev, et al. · Creative Surgery and Oncology
PDF
Efficacy of the 1st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens
2022 · K. V. Menshikov, A. V. Sultanbaev, et al. · Meditsinskiy sovet = Medical Council
PDF
Second Line Therapy for Advanced Endometrial Cancer. Literature Review and Clinical Case
2022 · K. V. Menshikov, A. V. Sultanbaev, et al. · Поволжский онкологический вестник
Works count: 9
Citation count: 11
H-index: 3
I10-index:
Year
Topic
Type